close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Apollomics, Inc.

Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
From Apollomics, Inc.
Via GlobeNewswire
Tickers APLM APLMW
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
From Apollomics, Inc.
Via GlobeNewswire
Tickers JMAC
Apollomics Announces Completion of Business Combination and Listing on Nasdaq
From Apollomics, Inc.
Via ACN Newswire
Tickers JMAC JMACU
Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations
From Apollomics, Inc.
Via GlobeNewswire
Tickers JMAC JMACU JMACW
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
From Apollomics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today